FilingReader Intelligence
Jacobio Pharmaceuticals plans HK$100m share buyback program
July 13, 2025 at 11:59 PM UTC•By FilingReader AI
Jacobio Pharmaceuticals Group plans to repurchase up to 78.9 million shares, representing 10% of issued shares, allocating up to HK$100 million for the program.
The buyback will be funded from the company's own resources, not IPO proceeds, with the mandate expiring June 10, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1167•Hong Kong Exchange
News Alerts
Get instant email alerts when Jacobio Pharmaceuticals Group publishes news
Free account required • Unsubscribe anytime